BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
43 results:

  • 1. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
    Gan DEH; Bustam AZ
    J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary thyroid Carcinoma.
    Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
    Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: a systematic review and network meta-analysis.
    Li X; Ding W; Zhang H
    Front Endocrinol (Lausanne); 2023; 14():1256209. PubMed ID: 38111707
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Improvement in neck ultrasound report quality following the implementation of European thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study.
    Wu J; Hu X; Seal P; Amin P; Diederichs B; Paschke R
    Eur Thyroid J; 2023 Aug; 12(5):. PubMed ID: 37439446
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. p18INK4C and brca1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
    Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
    Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An overview of the research progress of BRCA gene mutations in breast cancer.
    Wan A; Zhang G; Ma D; Zhang Y; Qi X
    Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188907. PubMed ID: 37172654
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
    Vashistha V; Katsoulakis E; Guo A; Price M; Ahmed S; Kelley MJ
    JCO Precis Oncol; 2023 Feb; 7():e2200518. PubMed ID: 36787508
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BMI-1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes.
    Liu JY; Jiang YN; Huang H; Xu JF; Wu YH; Wang Q; Zhu Y; Zheng B; Shen C; Qian WF; Shen J
    Cancer Sci; 2023 Feb; 114(2):449-462. PubMed ID: 36285479
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
    Shirota H; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Tada H; Shimada M; Niihori T; Aoki Y; Sugiyama I; Kawamura M; Yasuda J; Suzuki S; Iwaya T; Saito M; Saito T; Shibata H; Furukawa T; Ishioka C
    Cancer Med; 2023 Mar; 12(5):6170-6181. PubMed ID: 36251535
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. brca1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect
    Liu X; Liu H; Zeng L; Lv Y
    PeerJ; 2022; 10():e14052. PubMed ID: 36193432
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.
    Wu Y; Wang Z; Han L; Guo Z; Yan B; Guo L; Zhao H; Wei M; Hou N; Ye J; Wang Z; Shi C; Liu S; Chen C; Chen S; Wang T; Yi J; Zhou J; Yao L; Zhou W; Ling R; Zhang J
    Mol Ther; 2022 Jul; 30(7):2603-2617. PubMed ID: 35278676
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SYT7 plays a role in promoting thyroid cancer by mediating HMGB3 ubiquitination.
    Dong S; Pan J; Shen YB; Zhu LX; Chen L; Zhu F; Li H; Shen HX; Xia Q; Wu YJ; Xie XJ
    Endocr Relat Cancer; 2022 Mar; 29(4):175-189. PubMed ID: 35073278
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer.
    Wang W; Zhang W; Wu J; Zhou Z; Ma J
    Clin Exp Med; 2022 Aug; 22(3):385-392. PubMed ID: 34518949
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy.
    Lawal IO; Orunmuyi AT; Popoola GO; Mokoala KMG; Lengana T; Sathekge MM
    HIV Med; 2021 Nov; 22(10):907-916. PubMed ID: 34328251
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Squamous differentiation in surgically resected malignant pleural mesothelioma with neoadjuvant chemotherapy.
    Yotsukura M; Motoi N; Yoshida A; Yoshida Y; Nakagawa K; Watanabe SI
    Pathol Int; 2021 Oct; 71(10):692-696. PubMed ID: 34255921
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.
    Yadav MP; Ballal S; Sahoo RK; Tripathi M; Damle NA; Shamim SA; Kumar R; Seth A; Bal C
    PLoS One; 2021; 16(5):e0251375. PubMed ID: 33970962
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A phase I/II study of S-1 and irinotecan (iris) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).
    Samura H; Oki E; Okumura H; Yoshida T; Kai S; Kobayashi K; Kinjo T; Mori S; Tohyama T; Ohgaki K; Kawanaka H; Makiyama A; Ureshino N; Kotaka M; Shimose T; Ando K; Saeki H; Baba H; Maehara Y; Mori M
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):285-294. PubMed ID: 32734398
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast cancer.
    Schlosser S; Rabinovitch R; Shatz Z; Galper S; Shahadi-Dromi I; Finkel S; Jacobson G; Rasco A; Friedman E; Laitman Y; Evron E; Bernstein R; Weiss I; Sklair-Levy M; Ben-David MA
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):353-359. PubMed ID: 32084523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparisons of p53, KI67 and brca1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Predictive Risk-scoring Model For Central Lymph Node Metastasis and Predictors of Recurrence in Papillary thyroid Carcinoma.
    Jiang LH; Yin KX; Wen QL; Chen C; Ge MH; Tan Z
    Sci Rep; 2020 Jan; 10(1):710. PubMed ID: 31959758
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.